<u id="67938"></u>
  • <strike id="67938"></strike>
    <thead id="67938"><option id="67938"></option></thead>
    <object id="67938"></object><thead id="67938"><option id="67938"></option></thead>

    <strike id="67938"></strike>
    <nav id="67938"></nav>
    1. <strike id="67938"></strike>
      1. <th id="67938"></th>

        Biotechnology Product Manufacturing Industry Profile

        Report Page Length: 10-12
        Last Quarterly Update: 10/18/2021
        SIC Codes: 2836
        NAICS Codes: 325414
        Chapters Include:
        Industry Overview Trends & Challenges Industry Forecast
        Quarterly Industry Update Call Prep Questions Website & Media Links
        Business Challenges Financial Information Glossary & Acronyms
        View Full Sample Add To Cart

        Excerpt from Biotechnology Product Manufacturing Industry Profile

        Companies in this industry manufacture vaccines, toxoids, blood fractions, and culture media of plant or animal origin. Major companies include Amgen, Biogen, Genentech (owned by Switzerland-based Roche), and Gilead Sciences (all based in the US) as well as Bayer (Germany), CSL (Australia), Merck (Germany), Novo Nordisk (Denmark), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France).

        The global biotechnology industry generates total revenue of about $400 billion, according to Global Market Insights. Top regions for biotechnology include the US and Europe. Emerging markets include Australia, Canada, China, India, Singapore, Japan, and Brazil.

        The US biotechnology product manufacturing industry generates annual revenue of more than $100 billion. Because many drugs are now developed using biotechnology, the biotechnology and pharmaceutical industries overlap considerably. A separate industry report covers Pharmaceutical Manufacturing.

        COMPETITIVE LANDSCAPE

        Biotech firms face stiff competition from major pharmaceutical manufacturers and other companies seeking to be first with a new product or discovery. Development is often focused on high-demand, profitable markets such as cancer or rare disease treatment. Biopharmaceutical companies depend on gaining regulatory and insurance coverage approval for new treatments. They may also count on participation in government research or expedited approval programs.

        Because the market for potential products is so large, small biotechnology companies can co-exist successfully with large ones if they have expertise in a particular line of research. Smaller companies often team up with larger manufacturers, ...

         
        View Full Sample Add To Cart Return to the Industry Profile Menu

        Would you or your company benefit from having unlimited access to First Research's industry intelligence tools?

        Learn More About Subscription Options
         
        老司机精品视频100部456电影网6070影院狠狠夜夜大香蕉伊人狠狠射 <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <文本链> <文本链> <文本链> <文本链> <文本链> <文本链>